Gene symbol
|
Comparison
|
Microarray
|
---|
| |
p-value
|
q-value
|
Expression
|
FC
|
---|
CCRL2
|
Females
|
<0.05
|
<0.25
|
HSF > LSF
|
+2.22
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.02
|
CD1D
|
Females
|
<0.01
|
<0.25
|
HSF > LSF
|
+1.74
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.19
|
CD19
|
Females
|
<0.05
|
<0.25
|
HSF < LSF
|
-2.70
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
-1.05
|
CR2
|
Females
|
<0.01
|
<0.25
|
HSF < LSF
|
-3.13
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.01
|
CXCR7
|
Females
|
<0.05
|
<0.25
|
HSF < LSF
|
-2.83
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
-1.54
|
IL13RA1
|
Females
|
<0.01
|
<0.25
|
HSF > LSF
|
+2.55
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.04
|
IL27RA
|
Females
|
<0.01
|
<0.25
|
HSF < LSF
|
-1.38
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.04
|
IL6R
|
Females
|
<0.05
|
<0.25
|
HSF < LSF
|
-1.34
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.08
|
IL7R
|
Females
|
<0.05
|
<0.25
|
HSF < LSF
|
-1.84
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.01
|
TNFRSF1A
|
Females
|
<0.05
|
<0.25
|
HSF > LSF
|
+1.43
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
-1.03
|
TNFRSF1B
|
Females
|
<0.05
|
<0.25
|
HSF > LSF
|
+1.79
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
-1.12
|
TRAF5
|
Females
|
<0.05
|
<0.25
|
HSF < LSF
|
-1.83
|
|
Males
|
>0.10
|
>0.25
|
HSM = LSM
|
+1.12
|
- Significance level was set at p <0.05 and q <0.25; CCRL2 – chemokine (C-C motif) receptor-like 2; CD1d – CD1d molecule; CD19 – CD19 molecule; CR2 – complement component receptor 2; CXCR7 – chemokine (C-X-C motif) receptor 7; IL13RA1 – interleukin 13 receptor, alpha 1; IL27RA – interleukin 27 receptor, alpha; IL6R – interleukin 6 receptor; IL7R – interleukin 7 receptor; TNFRSF1A – tumor necrosis factor receptor superfamily, member 1A; TNFRSF1B – tumor necrosis factor receptor superfamily, member 1B; TRAF5 – TNF receptor-associated factor 5; FC – Fold change.